SYNETS
LIVE

Serial Number

98785348

Owner

Biogency Pty Ltd

Attorney

Jennifer A. Visintine

Filing Date

Oct 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SYNETS Trademark

Serial Number: 98785348 • Registration: 7990192

SYNETS is a trademark filed by Biogency Pty Ltd on October 4, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Biogency Pty Ltd (7 trademarks)

8/36 O'Riordan Street
Alexandra NSW 2015 , AU

Entity Type: 99

Trademark Details

Filing Date

October 4, 2024

Registration Date

October 21, 2025

Published for Opposition

September 2, 2025

Goods & Services

Food supplements, namely, anti-oxidants; capsules sold empty for pharmaceutical purposes; capsules sold empty for veterinary pharmaceutical preparations; chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; collagen based medicated supplements for use as nutritional supplements; decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; antioxidants in the nature of dietary supplements; dietary protein supplements; dietary supplements; dietary supplements for animals; dietary supplements with a cosmetic effect; effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; food supplements for medical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; herbal dietary supplements; dietary nutritional supplements; nutritional supplements; plant extracts, other than essential oils, being dietary supplements; medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for skin care; pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; chemical products in the nature of chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; natural pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; tablets being pharmaceuticals to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; food supplements for animals in the nature of vitamins; vitamin supplements; dietary food supplements; nutritional drinks being dietary food supplements; food supplements in the nature of dietary supplements

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 27, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 5, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 8, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2025 NWOS
NEW APPLICATION ENTERED
Oct 4, 2024 NWAP